ACE2 and acute respiratory distress syndrome: APN01 is a recombinant human ACE2 produced by APEIRON to treat ARDS, pulmonary arterial hypertension, and acute lung injury; briefly, it works by delaying the virus entry and spread and, therefore, may be of high benefit although the clinical trials are still ongoing (100).